[{"id":"35634c9b-1187-4711-9557-82019c40a446","acronym":"","url":"https://clinicaltrials.gov/study/NCT04315324","created_at":"2024-02-08T16:19:16.932Z","updated_at":"2024-07-02T16:35:20.107Z","phase":"Phase 2","brief_title":"Study to Test AKR1C3-Activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL)","source_id_and_acronym":"NCT04315324","lead_sponsor":"SWOG Cancer Research Network","biomarkers":" AKR1C3","pipe":" | ","alterations":" AKR1C3 expression","tags":["AKR1C3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AKR1C3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e OBI-3424"],"overall_status":"Recruiting","enrollment":" Enrollment 39","initiation":"Initiation: 02/08/2021","start_date":" 02/08/2021","primary_txt":" Primary completion: 08/01/2026","primary_completion_date":" 08/01/2026","study_txt":" Completion: 08/01/2027","study_completion_date":" 08/01/2027","last_update_posted":"2024-02-09"}]